The TRANSFORM-2 trial found Spravato patients were 70% more likely to achieve remission than those receiving a newly initiated oral antidepressant plus placebo, with statistically significant improvement within 24 hours
Spravato Treatment in West University Place, TX
Catalyst Health & Wellness serves West University Place — along with patients from Southside Place, Rice Military, Upper Kirby, the Texas Medical Center, and inner-loop Houston — as a fully REMS-certified Spravato provider. Dr. Ho, board-certified anesthesiologist and former pediatrician, leads every aspect of care. Our South Loop location at 6300 West Loop S is minutes from West U. Appointments run 5am–9pm, seven days a week.
Breakthrough Relief with Spravato Treatment West University
There’s a specific frustration that belongs to highly informed patients with treatment-resistant depression: you understand the pharmacology. You’ve read the clinical trial summaries. You’ve tried SSRIs, SNRIs, augmentation strategies — each one approached with the same rigor you’d bring to any complex problem. And still, the results haven’t matched what the evidence suggested they should be.
That gap isn’t a flaw in your approach. It reflects the neurobiological reality that roughly one in three people with major depressive disorder don’t achieve adequate relief from monoamine-targeting antidepressants — not because those medications are ineffective, but because their brain’s depression doesn’t live primarily in the serotonin pathway. It lives in the glutamate system. And until 2019, no FDA-approved treatment existed that could reach it.
Spravato (esketamine) reaches it. Healthline describes the drug as working by “increasing levels of glutamate, the most abundant chemical messenger in the brain,” producing “a greater impact on more brain cells at one time” than conventional antidepressants. The downstream effects — NMDA receptor blockade, mTOR activation, synaptogenesis — begin within hours of the first dose, not after weeks of monoamine accumulation. For West U patients who’ve been patient and systematic and still haven’t broken through, this is the mechanism that explains why: you haven’t been failing. You’ve been using the wrong biological key. Spravato is the right one.
What is Spravato Therapy?
The 2019 FDA approval of Spravato (esketamine) came with two designations that matter: breakthrough therapy and fast track — both reflecting the FDA’s assessment that the drug showed substantial improvement over existing options for a serious condition with inadequate alternatives. The approval was expanded in 2020 to include adults with MDD and active suicidal ideation, and in January 2025, the FDA made its most significant esketamine decision since 2019: approving it as a standalone monotherapy for TRD — the first time any antidepressant has been cleared to treat treatment-resistant depression without requiring a concurrent oral medication.
Research consistently shows powerful results:
What Our Patients Say
Take the First Step Toward Healing
Book Appointment
Conditions We Treat with Spravato Therapy in West University Place
Spravato holds FDA approval for two specific, well-documented clinical indications. At Catalyst Health & Wellness, we offer it for:
Your Spravato Therapy Journey at Catalyst Health & Wellness
Every step has been structured to be transparent, clinically rigorous, and logistically accessible for West U patients with demanding professional and family lives. Here's the full picture.
Step 1: Free Phone Consultation
No cost, no obligation. A clinical team member discusses your depression history, prior medication trials, and present circumstances — then gives you an honest, evidence-based assessment of whether Spravato makes clinical sense for you. If it doesn’t, you’ll hear that too.
Step 2: Insurance Verification & Prior Authorization
Spravato is covered by most major commercial insurance plans and Medicare for qualifying patients, but prior authorization is essentially universal. Our team handles that process entirely: benefit verification, clinical documentation, prior auth submission, insurer follow-up, and appeals when needed. You’ll know your coverage status before your first appointment — no surprises.
Step 3: Before Your First Visit
We’ll walk through everything in advance: dietary timing (no food for 2 hours before, no liquids for 30 minutes), what to bring, transportation logistics, and any notes on your current medications. Nothing about your first session will be unclear before you arrive.
Step 4: Day of Treatment
Budget approximately two to two-and-a-half hours. Driving is prohibited on treatment days — a designated driver or rideshare is required for every session.
Step 5: Your Treatment Session
You’ll settle into a private, purpose-built treatment room with a reclinable chair, soft adjustable lighting, warm blankets, and noise-cancelling headphones. Spravato is self-administered as a nasal spray under Dr. Ho’s direct clinical supervision, with continuous monitoring of vital signs, blood pressure, and response. Dissociation, if it occurs, peaks at approximately 40 minutes post-dose and resolves within the two-hour monitoring window. The experience typically becomes more comfortable with each subsequent session.
Step 6: Recovery & Aftercare
After monitoring concludes, leave with your driver. No driving until the morning after a full night’s sleep. Our team follows up between sessions and adjusts anything before your next appointment.
Step 7: Treatment Schedule & Maintenance
The protocol: twice weekly in weeks 1–4, once weekly in weeks 5–8, then individualized maintenance — weekly, biweekly, or monthly — based on your actual response trajectory, not a calendar.
The Science Behind Spravato for Treatment-Resistant Depression
Spravato’s evidence base spans more than a decade of research, two pivotal phase 3 trials, a 2025 monotherapy study, and nearly six years of post-approval real-world safety data.
The TRANSFORM-2 study (American Journal of Psychiatry) enrolled patients with confirmed TRD in a double-blind comparison of flexibly-dosed Spravato plus a newly initiated oral antidepressant versus antidepressant plus placebo. The Spravato arm was 70% more likely to achieve remission. Statistically significant improvement was measurable within 24 hours — a result that reflects the NMDA cascade and downstream synaptogenesis that Healthline describes as producing “a greater impact on more brain cells at one time” than conventional antidepressants targeting a single monoamine pathway.
The SUSTAIN-1 trial (JAMA Psychiatry) established durability with precision: patients who continued Spravato showed a hazard ratio of 0.49 for time to relapse versus placebo (p=0.003). The SUSTAIN-3 long-term extension study, published in 2025, confirmed that the benefits and acceptable safety profile of esketamine extend across multiple years of treatment — addressing one of the key clinical questions that followed the 2019 approval.
Key research findings:
- Esketamine’s mechanism — NMDA blockade → glutamate surge → AMPA activation → BDNF release → synaptogenesis — begins within hours, producing structural neural repair in areas of measurable synaptic loss caused by chronic depression
- The ASPIRE I and II trials confirmed significant depressive symptom reduction within 24 hours in patients with active suicidal ideation — the only FDA-approved rapid pharmacological option for that clinical population
- The SUSTAIN-3 extension study confirms sustained benefit and safety across multi-year use — the most comprehensive long-term dataset for esketamine published to date
- FDA approval in 77+ countries reflects a global regulatory consensus about the quality and reproducibility of this evidence
Why Choose Catalyst Health & Wellness for Spravato Treatment in West University Place
01
REMS-Certified Provider
FDA REMS certification is required for every Spravato treatment setting. Catalyst holds full REMS certification across all three Houston locations, with the South Loop location approximately four miles from West University Place. Every session meets every federal safety standard. The geographic proximity is practical, not incidental — for patients who need twice-weekly treatment during the induction phase, location matters.
02
Dr. Ho: The Right Credentials for This Medication
Esketamine is a dissociative NMDA receptor antagonist derived from an anesthetic. The physician overseeing its administration should understand anesthesia pharmacology, not just psychiatric prescribing. Dr. Ho’s board certification in anesthesiology means he understands esketamine’s pharmacokinetics, dosing parameters, and monitoring requirements at a depth that most psychiatrists — however skilled in their own domain — simply don’t have. His background as a former pediatrician adds a care culture that West U patients consistently describe as warm, precise, and genuinely attentive.
03
Insurance Navigation
We’ve handled prior authorizations across dozens of commercial insurance plans. Our team verifies benefits, prepares clinical documentation, submits the authorization, and follows up until it’s resolved. You’ll know your coverage status before your first appointment. If an appeal is needed, we handle that too.
04
Whole-Person Approach
West U patients often arrive having done extensive homework. Our team meets you there — engaging with the specifics of your history, your prior trial failures, the mechanisms that didn’t work and why, and what a realistic treatment trajectory looks like for your particular situation. Treatment plans are shaped by that full picture, not a one-size protocol. What this means in practice:
- Individualized clinical assessment before treatment begins
- Ongoing response monitoring with schedule adjustments as needed
- Coordination with your existing psychiatrist, prescriber, or therapist
- Long-term engagement that extends beyond the induction series
05
Extended Hours & Flexible Scheduling
West University Place residents — many in medicine, law, finance, and academia — manage demanding professional calendars that don’t leave room for standard weekday clinical appointments. Our 5am to 9pm hours, Monday through Sunday, at all three Houston locations make Spravato treatment compatible with virtually any schedule. The earliest appointments start before sunrise. Weekend sessions are available. You don’t have to choose between treatment and your professional commitments.
06
Comprehensive Treatment Options
Spravato is a powerful tool, but it’s not the only one. When your clinical picture benefits from a multi-modal approach, Catalyst offers complementary evidence-based treatments under the same roof:
Ketamine Therapy
Broader applications including anxiety, PTSD, chronic pain, OCD, and bipolar depression
TMS Therapy
Non-invasive magnetic brain stimulation for depression and OCD
Stellate Ganglion Block
Targeted nerve block treatment for PTSD and anxiety
Our goal is to find the right combination of treatments for your unique situation — not to fit you into a one-size-fits-all protocol.
07
Safe, Comfortable Environment
Our treatment rooms were designed specifically for the Spravato experience — not repurposed from other clinical uses. Each is private, quiet, and carefully arranged: reclinable chairs, soft adjustable lighting, warm blankets, noise-cancelling headphones. Dr. Ho’s clinical team is present and monitoring throughout every session. You’re observed, supported, and never alone.
Getting Started with Spravato Treatment in West University Place
West U’s identity — built on education, rigorous standards, and a genuine investment in quality — extends to the decisions residents make about their health. If you’ve applied those same values to depression treatment and the results still haven’t matched your effort, the most important thing to understand is this: you haven’t failed the system. The system hasn’t had the right tool for your biology. Spravato is that tool for a meaningful portion of treatment-resistant patients, and it’s available minutes from your front door.
Call 800-772-1242 for your free consultation. We’ll match the depth of your research with clinical specificity, answer your questions without deflection, and give you an honest picture of whether Spravato makes sense for your situation. No charge, no commitment, complete confidentiality.
Monday-Sunday, 6am-9pm
Free consultation
Insurance assistance
Three Houston locations
REMS-certified provider
Commonly Asked Questions
Get Help NowHow quickly does Spravato therapy work?
Many patients notice improvements within hours or days of their first treatment. The TRANSFORM-2 study showed significant improvement compared to placebo within 24 hours. This rapid action is one of Spravato’s most remarkable qualities, especially compared to traditional antidepressants that can take 4 to 8 weeks to work.
Is Spravato therapy safe?
Yes, when administered by trained medical professionals in a REMS-certified setting. Spravato underwent extensive clinical trials before FDA approval. Common side effects like dissociation, dizziness, and temporary blood pressure increases typically resolve within 1-2 hours. We monitor your vital signs throughout treatment to ensure your safety.
How many treatments will I need?
During the first month, you’ll receive Spravato twice weekly. In the second month, treatment typically decreases to once weekly. After that, most patients continue with maintenance treatments once weekly or every two weeks. The exact frequency depends on your individual response. We’ll work with you to find the schedule that keeps you feeling your best.
What does Spravato treatment feel like?
Experiences vary from person to person. Many patients describe feeling relaxed, calm, or somewhat disconnected from their surroundings. Some people experience mild visual or sensory changes. These effects are temporary and typically resolve within 1-2 hours after treatment ends. Most patients find the experience manageable and therapeutic.
Can I drive after a Spravato treatment?
No, you cannot drive yourself home after Spravato treatment, and you should not drive until the next day after a restful night’s sleep. You’ll need to arrange transportation both to and from your appointment. By the time you leave our facility after the 2-hour observation period, you’ll feel much clearer, but driving remains unsafe until the following day.
Will my insurance cover Spravato?
Many insurance plans cover Spravato for qualifying patients since it’s FDA-approved for treatment-resistant depression. Coverage varies by plan and typically requires prior authorization. Our team handles the insurance process for you, including benefits verification and prior authorization submissions.
Can I continue my current medications?
Spravato is always used alongside an oral antidepressant, so you’ll continue taking your prescribed antidepressant medication. We’ll coordinate with your prescribing physician to ensure your overall treatment plan is optimized. Some medications may require adjustment before starting Spravato, which we’ll discuss during your consultation.
Do I need a referral from my doctor?
No, you don’t need a referral to begin Spravato therapy at Catalyst Health & Wellness. However, coordination with your current prescribing physician is important since Spravato must be used alongside an oral antidepressant. We encourage communication between all members of your healthcare team.
Our Locations
Blog & insight
Insights on Healing, Growth, and Mental Wellness
June 13, 2026
FAQ: Common Questions About Ketamine Treatment Answered
If you've been researching ketamine therapy in Houston, chances are you've come across a lot of conflicting information. One article calls it a miracle cure. Another paints it as a risky party drug. Somewhere in between sits the truth, and you deserve straightforward answers before making any decision about your mental health or chronic pain…
June 10, 2026
Can Ketamine Therapy Help with Both Depression and Anxiety?
If you've spent years battling depression only to find anxiety creeping in alongside it (or vice versa), you're not imagining the connection. These two conditions show up together far more often than people realize, and the overlap can make recovery feel like trying to untangle a knot that keeps tightening. Traditional antidepressants and anti-anxiety medications…
June 7, 2026
Neuropathic Pain and Ketamine: Relief When Nerve Pain Won’t Quit
If you live with neuropathic pain, you already know it doesn't behave like ordinary pain. It burns when nothing touched you. It shocks down your leg while you're sitting still. It turns the brush of a bedsheet into something sharp. And the medications your doctor prescribed, the gabapentin, the duloxetine, maybe even opioids, take the…
Make an Appointment
Our mission is to empower individuals to overcome life’s challenges through professional psychological support.